Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients.

The effect of hyaluronidase on myocardial ischemic injury was examined in 13 patients with acute myocardial infarction, and the results were compared with 11 patients who did not receive hyaluronidase. A 35-electrode precordial mapping method was used to assess the rate of resolution of ST segment elevations. In the 11 control patients, the sum of ST segment elevations (sigmaST) fell after 2 hours to an average of 93.5% plus or minus 17.3% (SEM) and after 24 hours to 89.6% plus or minus 7.6% of the initial values, while the number of electrodes exhibiting ST segment elevations exceeding 0.1 mV (NST) fell to 98.0% plus or minus 12.3% and 94.3% plus or minus 10.4% of the initial values respectively. In the hyaluronidase-treated group, at the same time sigmaST fell significantly more (P less than 0.05), to 54.1% plus or minus 5.0% and 51.3% plus or minus 11.8% and NST was also more markedly reduced (P less than 0.05) to 50.7% plus or minus 7.8% and 50.1% plus or minus 12.4%, thus indicating that hyaluronidase can accelerate the reduction of myocardial ischemic injury in patients with acute myocardial infarction.

[1]  E. Barbato,et al.  THE EFFECTS OF LARGE INTRAVENOUS DOSES OF HYDROCORTISONE OR HYALURONIDASE ON THE ELECTROCARDIOGRAPHIC PATTERN OF ACUTE MYOCARDIAL INFARCTION. A COMPARATIVE CLINICAL AND EXPERIMENTAL STUDY. , 1965, Archivos del Instituto de Cardiologia de Mexico.

[2]  P. Libby,et al.  Reduction by Hyaluronidase of Myocardial Necrosis following Coronary Artery Occlusion , 1972, Circulation.

[3]  P R Reid,et al.  Myocardial-infarct extension detected by precordial ST-segment mapping. , 1974, The New England journal of medicine.

[4]  F. Pileggi,et al.  [The use of hyaluronidase in recent myocardial infarct. Electrocardiographic study]. , 1960, Arquivos brasileiros de cardiologia.

[5]  D. Reid,et al.  Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man. , 1972, Cardiovascular research.

[6]  P. Libby,et al.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. , 1972, The American journal of cardiology.

[7]  P. Maroko.  Editorial: Assessing myocardial damage in acute infarcts. , 1974, The New England journal of medicine.

[8]  H. Zimmerman,et al.  Intravenous injection of hyaluronidase in acute myocardial infarction: Preliminary report of clinical and experimental observations , 1959 .

[9]  E. Braunwald,et al.  The Reduction of Infarct Size — An Idea Whose Time (For Testing) Has Come , 1974, Circulation.

[10]  D. Moore.  AN EVALUATION OF HYALURONIDASE IN LOCAL AND NERVE BLOCK ANALGESIA: A REVIEW OF 519 CASES , 1950, Anesthesiology.

[11]  J. Seifter,et al.  STUDIES ON THE PHARMACOLOGY AND TOXICOLOGY OF TESTICULAR HYALURONIDASE , 1950, Annals of the New York Academy of Sciences.

[12]  P. Libby,et al.  Effect of pharmacologic agents on the function of the ischemic heart. , 1973, The American journal of cardiology.

[13]  P. Libby,et al.  Effects of Intraaortic Balloon Counterpulsation on the Severity of Myocardial Ischemic Injury following Acute Coronary Occlusion: Counterpulsation and Myocardial Injury , 1972, Circulation.

[14]  R. Tislow,et al.  SUBACUTE AND CHRONIC TOXICITY EXPERIMENTS WITH HYALURONIDASE , 1950, Annals of the New York Academy of Sciences.

[15]  E. Braunwald,et al.  Modification of myocardial infarction size after coronary occlusion. , 1973, Annals of internal medicine.

[16]  Britton Rc,et al.  Clinical uses of hyaluronidase; a current review. , 1953 .

[17]  A. Krotkiewski,et al.  Multi-lead electrocardiogram in relation to serum enzymes in acute myocardial infarction. , 1973, British heart journal.

[18]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[19]  J. Schwartzman.  Hyaluronidase; a review of its therapeutic use in pediatrics. , 1951, The Journal of pediatrics.